Identification of orphan histidine kinases that impact sporulation and enterotoxin production by Clostridium perfringens type F strain SM101 in a pathophysiologically-relevant ex vivo mouse intestinal contents model

• Published in: PLoS pathogens Vol. 19; no. 6; p. e1011429
• Main Authors: Mehdizadeh Gohari, Iman, Li, Jihong, Navarro, Mauricio A, Mendonça, Fábio S, Uzal, Francisco A, McClane, Bruce A
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01.06.2023; Public Library of Science (PLoS)
• Subjects: Analysis; Animal models; Animals; Biology and Life Sciences; Care and treatment; Clostridium infections; Clostridium perfringens; Clostridium perfringens - genetics; Complications and side effects; Context; Diarrhea; Enterotoxins - genetics; Food contamination; Food contamination & poisoning; Food poisoning; Gastrointestinal Contents; Genes; Histidine; Histidine Kinase - genetics; Intestine; Kinases; Laboratories; Medicine and Health Sciences; Mice; Minimum inhibitory concentration; Mutants; Phenotypes; Phosphorylation; Physical Sciences; Physiology, Pathological; Prevention; Research and Analysis Methods; Risk factors; RNA polymerase; Scientific equipment and supplies industry; Spores, Bacterial - genetics; Sporulation; Toxins; Chile; United States
• ISSN: 1553-7374; 1553-7366; 1553-7374
• DOI: 10.1371/journal.ppat.1011429

When causing food poisoning or antibiotic-associated diarrhea, Clostridium perfringens type F strains must sporulate to produce C. perfringens enterotoxin (CPE) in the intestines. C. perfringens is thought to use some of its seven annotated orphan histidine kinases to phosphorylate Spo0A and initiate sporulation and CPE production. We previously demonstrated the CPR0195 orphan kinase, but not the putative CPR1055 orphan kinase, is important when type F strain SM101 initiates sporulation and CPE production in modified Duncan-Strong (MDS) sporulation medium. Since there is no small animal model for C. perfringens sporulation, the current study used diluted mouse intestinal contents (MIC) to develop an ex vivo sporulation model and employed this model to test sporulation and CPE production by SM101 CPR0195 and CPR1055 null mutants in a pathophysiologically-relevant context. Surprisingly, both mutants still sporulated and produced CPE at wild-type levels in MIC. Therefore, five single null mutants were constructed that cannot produce one of the previously-unstudied putative orphan kinases of SM101. Those mutants implicated CPR1316, CPR1493, CPR1953 and CPR1954 in sporulation and CPE production by SM101 MDS cultures. Phosphorylation activity was necessary for CPR1316, CPR1493, CPR1953 and CPR1954 to affect sporulation in those MDS cultures, supporting their identity as kinases. Importantly, only the CPR1953 or CPR1954 null mutants exhibited significantly reduced levels of sporulation and CPE production in MIC cultures. These phenotypes were reversible by complementation. Characterization studies suggested that, in MDS or MIC, the CPR1953 and CPR1954 mutants produce less Spo0A than wild-type SM101. In addition, the CPR1954 mutant exhibited little or no Spo0A phosphorylation in MDS cultures. These studies, i) highlight the importance of using pathophysiologically-relevant models to investigate C. perfringens sporulation and CPE production in a disease context and ii) link the CPR1953 and CPR1954 kinases to C. perfringens sporulation and CPE production in disease-relevant conditions.